Causal Effects in Principal Strata Defined by Antidrug Antibodies R package BPrinStratTTE version 0.0.7 Bayesian models to estimate causal effects of biological treatments on time-to-event endpoints in clinical trials with principal strata defined by the occurrence of antidrug antibodies. The methodology is based on Frangakis and Rubin (2002) <doi:10.1111/j.0006-341x.2002.00021.x> and Imbens and Rubin (1997) <doi:10.1214/aos/1034276631>, and here adapted to a specific time-to-event setting. Software Depends: R (>= 3.4.0) Imports: dplyr, furrr, magrittr, methods, purrr, Rcpp (>= 0.12.0), RcppParallel (>= 5.0.1), rstan (>= 2.18.1), rstantools (>= 2.4.0), stats, stringr, tibble LinkingTo: BH (>= 1.66.0), Rcpp (>= 0.12.0), RcppEigen (>= 0.3.3.3.0), RcppParallel (>= 5.0.1), rstan (>= 2.18.1), StanHeaders (>= 2.18.0) Suggests: spelling Christian Stock <christian.stock@boehringer-ingelheim.com> Comprehensive R Archive Network (CRAN) Christian Stock [aut, cre] (ORCID: <https://orcid.org/0000-0002-3493-3234>), Emma Torrini [aut], Boehringer Ingelheim Pharma GmbH & Co. KG [cph, fnd] GPL (>= 3) 2024-04-13 application/tgz https://CRAN.R-project.org/package=BPrinStratTTE doi:10.32614/CRAN.package.BPrinStratTTE en-US